Transasia Bio-Medicals Ltd is India’s largest In Vitro Diagnostics Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Electrophoresis, Molecular Diagnostics, Diabetes Management, and Microbiology. Transasia was incepted in the year 1979 and is headquartered in Mumbai. Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba Transasia Group has spread its footprint across the USA, UK, Europe, Turkey, and Eastern Europe, Russia and France, by means of various acquisitions – Erba Germany, Erba Czech Republic, Erba Russia, Erba Turkey, Erba France, Erba Diagnostics (USA), Erba Molecular (UK), Diamedix (USA), Delta Biologicals (Italy), ImmunoVision (USA), JAS Diagnostics Inc. (USA) and Drew Scientific (USA). Today, the Erba Transasia Group serves millions across 100 countries. Transasia manufactures and markets Equipment and Reagents, with an impressive installation base of above 50,000 types of equipment across India. Transasia’s commitment to healthcare has been recognized by various awards and accolades, the latest one from the World Economic Forum which conferred the organization with ‘Global Growth Company Award, 2014’, ‘Most Indigenous Medical Equipment Devices Company’, ‘Pioneer for the Make in India Concept’ Award, by the Hon’ble Minister of Science & Technology & Earth Sciences, Government of India and recently was bestowed with the ‘Maker in India’ Award 2015. With a vision of being recognized as a ‘local for global’ organization, Transasia continues to provide doctors and patients with reliable, affordable, and innovative Medical Diagnostic Systems.